Evidence map›Paper›PMID 32140850›Full record

ArticleEJNMMI research2020

Kinetic modeling of

Anna Ringheim, Guilherme de Carvalho Campos Neto, Udunna Anazodo, Lumeng Cui, Marcelo Livorsi da Cunha, Taise Vitor, Karine Minaif Martins, Ana Cláudia Camargo Miranda, Marycel Figols de Barboza, Leonardo Lima Fuscaldi and 3 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. CXCR4-targeted PET imaging of glioblastoma using [EJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Dual-time-point dynamicAnnals of nuclear medicine · 2024
    Article
  6. Article
  7. Determining the optimal pharmacokinetic modelling and simplified quantification method of [European journal of nuclear medicine and molecular imaging · 2024
    Article
  8. Combined whole-body dynamic and static PET/CT with low-dose [European journal of nuclear medicine and molecular imaging · 2024
    Article
  9. First-in-human study of PSMA-targeting agent, [European journal of nuclear medicine and molecular imaging · 2024
    Article
  10. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [European journal of nuclear medicine and molecular imaging · 2024
    Article
  11. Article
  12. Comparison of parametric imaging and SUV imaging with [European journal of nuclear medicine and molecular imaging · 2024
    Article
  13. Article
  14. Direct Patlak Reconstruction of [International journal of molecular sciences · 2023
    Article
  15. Article
  16. Article
  17. Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  18. Influences on PET Quantification and Interpretation.Diagnostics (Basel, Switzerland) · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Anna RingheimHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil. anna.m.ringheim@gmail.com.ORCID http://orcid.org/0000-0001-8718-0582
Guilherme de Carvalho Campos NetoHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Udunna AnazodoLawson Health Research Institute, St Joseph's Health Care, 268 Grosvenor Street, London, Ontario, N6A 4V2, Canada.
Lumeng CuiDivision of Biomedical Engineering, University of Saskatchewan, 57 Campus Drive, Saskatoon, Saskatchewan, SK, S7N 5A9, Canada.
Marcelo Livorsi da CunhaHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Taise VitorHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Karine Minaif MartinsHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Ana Cláudia Camargo MirandaHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Marycel Figols de BarbozaHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Leonardo Lima FuscaldiHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Gustavo Caserta LemosHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
José Roberto Colombo JuniorHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Ronaldo Hueb BaroniHospital Israelita Albert Einstein, Avenida Albert Einstein 627/701, Morumbi, Sao Paulo, SP, CEP 05652-900, Brazil.
Hospital Israelita Albert Einstein · BRUniversity of Saskatchewan · CAWestern University · CA

Funding

Mitacs IT10545
6 · The paper itself

Abstract

backgroundThe positron emission tomography (PET) ligand

resultsFifteen patients with histologically proven primary prostate cancer underwent a 60-min dynamic

conclusions

Indexed as

Arterial blood samplingImage-derived input functionKinetic modelingPET/MRProstate cancerPSMASUV

Identifiers

PMID32140850
PMCPMC7058750
OpenAlexW3012895697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.